Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh Verma

Showing results (61-70 of 785) with videos related to

Pageof 79
Sort By:
Circulation|June 28, 2006
South Asians and cardiovascular risk: what clinicians should knowMilan Gupta, Narendra Singh, Subodh Verma
Current Opinion in Cardiology|December 22, 2018
Early failure of aortic bioprostheses: what are the mechanisms?Amine Mazine, Subodh Verma, Bobby Yanagawa
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 15, 2003
C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formationSubodh Verma, Edward T H Yeh
The Journal of Thoracic and Cardiovascular Surgery|April 20, 2013
The molecular fingerprint of bicuspid aortopathyPaul W M Fedak, Subodh Verma
Seminars in Thoracic and Cardiovascular Surgery|July 8, 2017
The Dance of 2 Devils: Mitral Valve Repair and Functional Mitral StenosisBobby Yanagawa, Vincent Chan, Subodh Verma
Clinical Chemistry|December 20, 2008
Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevanceIshwarlal Jialal, Subodh Verma, Sridevi Devaraj
Metabolism: Clinical and Experimental|March 24, 2007
Vascular dysfunction: a Janus face of visfatin in diabetes?Hwee Teoh, Fina Lovren, Subodh Verma
The Journal of Thoracic and Cardiovascular Surgery|February 9, 2018
Mitral valve repair with resection versus neochordae: A call for high-quality evidenceAmine Mazine, Subodh Verma, Bobby Yanagawa
JACC. Basic to Translational Science|February 3, 2021
DAPA-CKD: The Beginning of a New Era in Renal ProtectionDavid Z I Cherney, Subodh Verma
Diabetologia|August 23, 2018
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art reviewSubodh Verma, John J V McMurray
Pageof 79

Showing results (61-70 of 785) with videos related to

Sort By:
Pageof 79
Circulation|June 28, 2006
South Asians and cardiovascular risk: what clinicians should knowMilan Gupta, Narendra Singh, Subodh Verma
Current Opinion in Cardiology|December 22, 2018
Early failure of aortic bioprostheses: what are the mechanisms?Amine Mazine, Subodh Verma, Bobby Yanagawa
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 15, 2003
C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formationSubodh Verma, Edward T H Yeh
The Journal of Thoracic and Cardiovascular Surgery|April 20, 2013
The molecular fingerprint of bicuspid aortopathyPaul W M Fedak, Subodh Verma
Seminars in Thoracic and Cardiovascular Surgery|July 8, 2017
The Dance of 2 Devils: Mitral Valve Repair and Functional Mitral StenosisBobby Yanagawa, Vincent Chan, Subodh Verma
Clinical Chemistry|December 20, 2008
Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevanceIshwarlal Jialal, Subodh Verma, Sridevi Devaraj
Metabolism: Clinical and Experimental|March 24, 2007
Vascular dysfunction: a Janus face of visfatin in diabetes?Hwee Teoh, Fina Lovren, Subodh Verma
The Journal of Thoracic and Cardiovascular Surgery|February 9, 2018
Mitral valve repair with resection versus neochordae: A call for high-quality evidenceAmine Mazine, Subodh Verma, Bobby Yanagawa
JACC. Basic to Translational Science|February 3, 2021
DAPA-CKD: The Beginning of a New Era in Renal ProtectionDavid Z I Cherney, Subodh Verma
Diabetologia|August 23, 2018
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art reviewSubodh Verma, John J V McMurray
Pageof 79